7 Simple Changes That Will Make An Enormous Difference To Your ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There aren't many studies on how exposure to ADHD for a long time could affect a fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological conditions like hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should weigh the benefits of taking it against the potential risks to the fetus. Physicians don't have the data to provide clear recommendations but they can provide information on risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers used a vast population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to make sure that the classification was accurate and to minimize any bias.

The study of the researchers was not without limitations. Most important, they were unable to separate the effects of the medication from the disorder at hand. This limitation makes it difficult for researchers to establish whether the few associations observed between the groups that were exposed to the use of medications, or if they were affected by comorbidities. Researchers also did not study long-term outcomes for offspring.

The study showed that infants whose mother took ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU), compared to those whose mothers did not use any medication during pregnancy or stopped taking their medication before or during pregnancy. The reason genetic testing for adhd medications this was central nervous system disorders, and the higher risk of admission was not found to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be independent of the type of medication used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications in early pregnancies could be offset by the greater benefits for baby and mother of continued treatment for the woman's disorder. Physicians should speak with their patients about this and as much as possible, assist them develop coping strategies that could reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the question of whether to continue or stop treatment during pregnancy is one that doctors are having to confront. Often, these decisions are made in the absence of clear and authoritative evidence regardless, so doctors must weigh their knowledge about their experiences, the experiences of other doctors, and what research suggests about the subject, along with their best judgment for each patient.

The issue of potential risks to the infant can be extremely difficult. The research that has been conducted on this topic is based on observations rather than controlled studies and a lot of the results are in conflict. The majority of studies focus on live births, which can underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study discussed in this journal club addresses these limitations by examining data on both live and deceased births.

The conclusion: While certain studies have demonstrated a positive association between ADHD medications and the possibility of certain birth defects, other studies have found no connection, and most studies have a neutral or slightly negative effect. In all cases it is imperative to conduct a thorough evaluation of the risks and benefits is required.

For women suffering from ADHD and ADD, the decision to stop medication is difficult, if not impossible. In a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can adhd medication help with memory, Thesocialdelight official blog, cause depression, feelings of isolation and family conflict for patients with ADHD. Furthermore, a loss of medication may affect the ability to perform job-related tasks and drive safely, which are important aspects of daily life for many people with ADHD.

She suggests women who are unsure about whether to continue or stop medication in light of their pregnancy, consider informing family members, friends, and coworkers on the condition, its effects on daily life, and the advantages of continuing the current treatment plan. Educating them can also help the woman feel supported as she struggles with her decision. Certain medications can be passed through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is important to be aware that the drug could be transferred to the infant.

Birth Defects and Risk of

As the use and abuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (adhd and anxiety medication), increases the concern over the potential adverse effects of the drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers used two huge datasets to analyze over 4.3 million pregnancies and determine if the use of stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester ADHD medication use was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The authors of the study found no link between the use of early medications and congenital abnormalities such as facial clefting or club foot. The results are in the same vein as previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication prior to the time of pregnancy. This risk increased during the latter half of pregnancy when many women began to stop taking their medication.

Women who used ADHD medication in the first trimester of their pregnancies were also more likely to experience caesarean section, low Apgar score after delivery and a baby who needed breathing assistance at birth. The authors of the study were not able to eliminate bias due to selection because they restricted the study to women with no other medical conditions that might have contributed to the findings.

The researchers hope their research will aid in the clinical decisions of doctors who encounter pregnant women. They suggest that although the discussion of the risks and benefits is crucial however, the decision to stop or maintain medication should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication is a possibility to consider, it is not advised due to the high rate depression and other mental problems among women who are pregnant or recently gave birth. Further, the research suggests that women who decide to stop taking their medications are more likely to have difficulties adapting to life without them following the birth of their baby.

Nursing

It can be a challenge to become a mom. Women who suffer from adhd medication guanfacine are often faced with a number of difficulties when they have to manage their symptoms, go to doctor appointments, prepare for the birth of a child and adjust to a new routine. This is why many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The risk to nursing infant is low because the majority of stimulant medication is absorbed through breast milk in low amounts. The rate of medication exposure will differ based on dosage the medication is administered, its frequency and the time of the day. In addition, various medications are introduced into the baby's system via the gastrointestinal tract or through breast milk. The impact on a newborn's health is not fully understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the absence of research. It's a difficult choice for the woman who must weigh the advantages of taking her medication as well as the risk to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal period.

Numerous studies have proven that women can continue to take their ADHD medication without risk during pregnancy and breast-feeding. As a result, many patients are choosing to do so and, in consultation with their physician, they have discovered that the benefits of maintaining their current medication far outweigh any potential risks.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help women with ADHD recognize their symptoms and underlying disorder and learn about treatments and to reinforce existing strategies for managing adhd without medication. This should involve a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of discussion of a management plan for both the mother and child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.